000			01929cam a2200253 4500
001			9780323568579
008			220107t2019 xxu||||| |||| 00| 0 eng d
020			_a9780323568579
020			_a9780323543910
041			_aeng
100			_aBenitz, William E.
245		0	_aInfectious disease and pharmacology: neonatology questions and controversies
260			_aPhiladelphia : _bElsevier, _c2019
300			_a1 online resource (xiv, 292 pages):illustrations.
490			_aNeonatology questions and controversies
505			_aPart 1: Infectious disease. Management of the asymptomatic newborn at risk for sepsis -- Empirical therapy for neonatal sepsis -- When and how to treat neonatal CMV infections -- Neonatal herpes simplex virus infection -- Antibiotic stewardship -- Candida prophylaxis -- Diagnosis, risk factors, outcomes, and evaluation of invasive candida infections -- When to perform lumbar puncture in infants at risk for meningitis in the neonatal intensive care unit -- Biomarkers in diagnosis of neonatal sepsis -- Congenital Zika syndrome -- Part 2: Pharmacology. Pharmacokinetic considerations in neonates -- Neonatal pharmacogenetics -- Antibiotic considerations for necrotizing enterocolitis -- Antibiotic dosing considerations for term and preterm infants -- Antifungal dosing considerations for term and preterm infants -- Antiviral dosing considerations for term and preterm infants -- Antiepileptic drug therapy in neonates -- Neuroprotective therapies in neonates -- Pharmacologic therapy for neonatal abstinence syndrome -- Therapies for gastroesophageal reflux in neonates"
690			_aNewborn infants
690			_aNeonatology
690			_aAnti-infective agents
700			_aSmith, P.Brian
700			_aPolin, Richard A.
856			_uhttps://go.openathens.net/redirector/nhs?url=https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20160002504
999			_c58615 _d58615